Dean Mattox
Family Medicine · Angola, INNPI 1801828546
Payments from drug & device makers
Across 68 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$171
- Pfizer$155
- Exact Sciences$95
- AbbVie$82
- Novo Nordisk$81
- Abbott$68
- plus $534 from 21 others
What the payments were for
- Food & beverage$1,17199%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 10 | $171 |
| Pfizer | 5 | $155 |
| Exact Sciences | 6 | $95 |
| AbbVie(2 entities) | 6 | $82 |
| Novo Nordisk | 5 | $81 |
| Abbott | 4 | $68 |
| Amgen | 4 | $62 |
| Astellas Pharma US Inc | 3 | $60 |
| Dexcom, Inc. | 3 | $48 |
| Johnson & Johnson | 2 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $39 |
| Lilly USA, LLC | 2 | $32 |
| Viatris Specialty LLC | 2 | $32 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Philips North America LLC | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Mylan Specialty L.p. | 1 | $18 |
| Corium, LLC | 1 | $18 |
| Bayer | 1 | $15 |
| Shield Therapeutics Inc | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Merck | 1 | $12 |
| VBI Vaccine (delaware) Inc. | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $11 |
How this compares
$1,186 in reported general payments places this provider in the 60th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 65 | $69,672 |
| EliquisApixaban | 56 | $61,213 |
| OzempicSemaglutide | 22 | $34,509 |
| TrulicityDulaglutide | 18 | $34,484 |
| XareltoRivaroxaban | 38 | $26,022 |
| MounjaroTirzepatide | 19 | $20,178 |
| JardianceEmpagliflozin | 17 | $19,770 |
| Breo ElliptaFluticasone/Vilanterol | 30 | $16,339 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $8,574 |
| MyrbetriqMirabegron | 27 | $7,436 |
| PremarinEstrogens, Conjugated | 11 | $5,825 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $5,037 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $3,434 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 28 | $3,199 |
| Atorvastatin Calcium | 446 | $2,972 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $12 | $69,67265 claims |
| PfizerEliquis, Premarin | $155 | $67,03967 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $32 | $54,66137 claims |
| Novo NordiskOzempic | $81 | $34,50922 claims |
| Johnson & JohnsonXarelto | $41 | $26,02238 claims |
| AstraZenecaSymbicort | $171 | $8,57421 claims |
| Astellas Pharma US IncMyrbetriq | $60 | $7,43627 claims |
| AbbVieSynthroid | $82 | $77017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Angola
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
- Jonathan ConditMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.